Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
04
01
2021
accepted:
21
06
2021
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
14
9
2021
Statut:
epublish
Résumé
Patients with COPD often have reduced physical activity, which can impair health status. Real-world data can provide valuable information on the health and functional status of patients with COPD treated with tiotropium/olodaterol. AERIAL
Identifiants
pubmed: 34513983
doi: 10.1183/23120541.00004-2021
pii: 00004-2021
pmc: PMC8419313
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT03165045']
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright ©The authors 2021.
Déclaration de conflit d'intérêts
Conflict of interest: A. Gillissen reports nonfinancial support from Boehringer Ingelheim during the conduct of the study. Conflict of interest: A. Marseille is an employee of Boehringer Ingelheim. Conflict of interest: D. Skowasch reports personal fees from Boehringer Ingelheim, AstraZeneca, Berlin-Chemie, GSK, Grifols and Novartis, outside the submitted work. Conflict of interest: J. Ritz is an employee of Boehringer Ingelheim. Conflict of interest: M. Mattiucci-Guehlke is an employee of Boehringer Ingelheim. Conflict of interest: S. Pabst has nothing to disclose. Conflict of interest: T. Greulich reports personal fees from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, GSK, Novartis, Roche and Chiesi, and grants and personal fees from CSL Behring and Grifols, outside the submitted work. Conflict of interest: R. Koczulla has nothing to disclose.
Références
Eur Respir J. 2009 Feb;33(2):262-72
pubmed: 19010994
Eur Respir J. 2017 Apr 19;49(4):
pubmed: 28424359
Respir Med. 2010 Jul;104(7):1005-11
pubmed: 20167463
Am J Respir Crit Care Med. 2020 May 1;201(9):e56-e69
pubmed: 32283960
Respir Med. 2016 Feb;111:64-71
pubmed: 26775251
Dtsch Arztebl Int. 2018 Sep 14;155(37):599-605
pubmed: 30282573
Int J Chron Obstruct Pulmon Dis. 2016 Feb 26;11:407-15
pubmed: 27013871
Thorax. 2006 Sep;61(9):772-8
pubmed: 16738033
Eur Respir J. 2015 Apr;45(4):969-79
pubmed: 25573406
Respir Med. 2018 Oct;143:67-73
pubmed: 30261995
Pulm Ther. 2020 Dec;6(2):261-274
pubmed: 32557394
Int J Chron Obstruct Pulmon Dis. 2019 Oct 11;14:2343-2354
pubmed: 31632003
Health Qual Life Outcomes. 2009 Mar 25;7:26
pubmed: 19320988
Respirology. 2017 Feb;22(2):251-262
pubmed: 28102972
Respir Med. 2017 Oct;131:77-84
pubmed: 28947047
Adv Ther. 2020 Oct;37(10):4175-4189
pubmed: 32671684
Respir Res. 2016 Jun 18;17(1):73
pubmed: 27316465
Health Qual Life Outcomes. 2003 Apr 28;1:13
pubmed: 12773199
Int J Chron Obstruct Pulmon Dis. 2019 Jul 04;14:1441-1453
pubmed: 31308649
Int J Chron Obstruct Pulmon Dis. 2016 Apr 27;11:891-8
pubmed: 27217742
Eur Respir J. 2010 Aug;36(2):292-300
pubmed: 20075059
Respir Res. 2006 Apr 07;7:62
pubmed: 16603063
Pulm Pharmacol Ther. 2015 Jun;32:53-9
pubmed: 25956072
Adv Ther. 2017 Jan;33(12):2188-2199
pubmed: 27796912
Chest. 2002 May;121(5):1441-8
pubmed: 12006426
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465818755091
pubmed: 29439648